Original Research
Published on 18 Aug 2023
Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
in Hematologic Malignancies
- 3,760 views
- 3 citations







